Athens Medical C.S.A. (ATH: IATR)

Market Cap	141.81M
Revenue (ttm)	258.36M
Net Income (ttm)	8.08M
Shares Out	86.74M
EPS (ttm)	0.09
PE Ratio	15.64
Forward PE	n/a
Dividend	0.02 (1.19%)
Ex-Dividend Date	Jul 22, 2024

Volume	8,476
Average Volume	5,980
Open	1.605
Previous Close	1.685
Day's Range	1.605 - 1.675
52-Week Range	1.440 - 2.030
Beta	1.13
RSI	57.12
Earnings Date	Jan 3, 2025

About Athens Medical C.S.A.

Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and neuro- and spine surgery services. It also provides medical services for range of orthopedics, such as foot and ankle, hand and wrist, hip, knee, shoul...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1983
• Employees: 3,230
• Stock Exchange: Athens Stock Exchange
• Ticker Symbol: IATR

Financial Performance

In 2023, Athens Medical C.S.A.'s revenue was 258.36 million, an increase of 10.69% compared to the previous year's 233.42 million. Earnings were 8.08 million, an increase of 18.05%.